AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03208387 — intervention group
Intervention type: BEHAVIORAL
Intervention: Beery Test of Visual Motor Integration 6th edition
Description: Measure designed to assess visual-motor functioning of subjects between the ages of 2-99 years old by copying designs using paper and pencil.
Study NCT03208387 — intervention group
Intervention type: BEHAVIORAL
Intervention: Grooved Pegboard
Description: This is a standard assessment of fine motor functioning and dexterity by asking the subject to place metal pegs into holes on a board.
Study NCT01596699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Description: 0.5 mg/kg (max 15 mg or max 6 mg), IV, Day -12 to Day -10 pre-HCT
Study NCT01596699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Description: 0.8 mg/kg/dose q6hrs or 1.1 mg/kg/dose q6hrs, IV, Day -9 to Day -6 pre-HCT
Study NCT01596699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: 40 mg/m2 or 1.33 mg/kg, IV, Day -5 to Day -2 pre-HCT
Study NCT01596699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofarabine
Description: 10 mg/m2 or 0.33 mg/kg, IV, Day -5 to Day -2 pre-HCT
Study NCT01991678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 145 mg/m2 NKTR 102
Study NCT01991678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 120 mg/m2 NKTR 102
Study NCT01991678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 50 mg/m2 NKTR 102
Study NCT01811329 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dairy fat
Study NCT01811329 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dairy fat + MFGM
Description: BPC50, a dairy fraction rich in milk fat globule membrane proteins and phospholipids manufactured by Fonterra, will make up 50% of the shake's total fat.
Study NCT01811329 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Palm fat
Study NCT01811329 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Palm fat + MFGM
Description: BPC50, a dairy fraction rich in milk fat globule membrane proteins and phospholipids manufactured by Fonterra, will make up 50% of the shake's total fat.
Study NCT00295529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention
Description: Educational materials available at end of study
Study NCT04497571 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Piezoelectric osteotomy.
Description: Implants placed using the ultrasonic technique.
Study NCT03582917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alphacalcidol
Description: Alphacalcidol 0,5mg tablet
Study NCT04497571 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional drilling
Description: Implants placed using drilling technique
Study NCT03208387 — intervention group
Intervention type: BEHAVIORAL
Intervention: PedsQL Multidimensional Fatigue Scale
Description: Designed to measure fatigue in pediatric patients (ages 5-17 years) and is comprised of the General Fatigue Scale (6 items), Sleep/Rest Fatigue Scale (6 items) and Cognitive Fatigue Scale (6 items).
Study NCT03208387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: Images will be acquired on a 3.0 Tesla MRI scanner at each of the four study sites. At MSK, resting state fMRI data will be obtained using a 3T GE scanner with an 8-channel head coil (Discovery 750w DV25)
Study NCT03025620 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rapeseed oil
Description: Active comparator arm : Dietary Supplement: rapeseed oil supplementation (10g per day) and margarine with a high level of alpha-linolenic acid (12.5g per day) during 42 days.
Study NCT03025620 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Sunflower oil
Description: Placebo comparator arm : Dietary Supplement: sunflower oil supplementation (10g per day) and margarine with a high level of inoleic acid (12.5g per day) during 42 days.
Study NCT02066558 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Carbon monoxide
Description: carbon monoxide, 4.7, Purity 99.997, inhalation of carbon monoxide in a volume corresponding to carboxyhemoglobin 10 and 20%, calculated from baseline Hg and body mass.
Study NCT02066558 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02520531 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Scorpio PS (posterior stable)
Description: Implantation of total knee prosthesis
Study NCT02520531 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Scorpio NRG PS
Description: Implantation of total knee prosthesis
Study NCT04341922 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic
Description: The intervention focuses on 1) teaching participants how to discriminate between functional and dysfunctional worry (what are solvable problems vs. what is worry, i.e. unsolvable thoughts?) 2) providing participants with skills to solve functional worry topics (e.g. set time and make a workable plan to be prepared for possible negative outcomes \[e.g. becoming unemployed\]), 3) helping participants to reduce unhelpful behaviors that may reinforce worry (e.g., limit excessive news consumption, refrain from assurance seeking behaviors), 4) providing participants with skills to approach dysfunctional worry (e.g., not engage in worrisome thoughts, just leave them), and 5) increase the behavioral repertoire (take walks, engage in activities that promote health without putting oneself at risk to become infected).
Study NCT03884972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trabectedin
Description: Given IV
Study NCT03884972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT01743937 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary occlusion with balloon inflation
Study NCT02676739 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adderall XR
Study NCT02676739 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Adderall XR
Study NCT03770338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: 20ug dosage daily injection, 1-month preoperative
Study NCT02747459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensory Supported Swimming
Description: A swimming and water safety program for children with autism spectrum disorders. Individualized instruction utilizing evidence-based teaching methods and sensory modifications.
Study NCT03376204 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06719648 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix + L-Prf
Description: Incisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator.~Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning.~Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted.~Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning.~Root Preparation: The exposed root surfaces were smoothed and cleaned.
Study NCT06719648 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective Tissue graft + L-Prf
Description: Incisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator.~Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning.~Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted.~Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning.~Root Preparation: The exposed root surfaces were smoothed and cleaned.
Study NCT00967187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevirimat dimeglumine
Description: Patients will be treated with MPC-4326 200mg monotherapy for 14 days. Once the Day 15 viral load results become available, patients, who achieve at least a 0.5 log10 reduction in viral load by Day 15 will have the option to continue on both MPC-4326 and an optimized background regimen (OBR) through Week 72.
Study NCT00967187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevirimat dimeglumine
Description: Patients will be treated with MPC-4326, 300 mg monotherapy for 14 days. Once the Day 15 viral load results become available patients who achieve at least a 0.5 log10 reduction in viral load by Day 15 will have the option to continue on both MPC-4326 and an optimized background regimen (OBR) through Week 72.
Study NCT01543269 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ZYT1
Description: Oral dose of ZYT1 in fasting condition with 240±10 ml of water at sitting position in ambient temperature.
Study NCT01543269 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablets
Description: Oral dose of Placebo in fasting condition with 240±10 ml of water at sitting position in ambient temperature.
Study NCT04596358 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Evaluation of adherence to the Mediterranean diet through the administration of the Med Diet Score questionnaire.
Study NCT01825499 — intervention group
Intervention type: OTHER
Intervention: Registry
Study NCT03559452 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Description: 300 eccentric contractions of the knee extensors
Study NCT03345459 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ICare Prevent (internet-based treatment for depression in college students)
Description: ICare Prevent (internet-based treatment for depression in college students): 7 weekly sessions and 1 booster session. Each session requires about 30-45 minutes to complete. All sessions are accessed online, and it is a guided treatment (i.e., each patient provided an eCoach).
Study NCT04449549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib and Paclitaxel
Description: The BCR-Abl kinase inhibitor nilotinib demonstrated greater than additive activity in combination with the anti-tubulin agent paclitaxel in preclinical xenograft models, justifying the clinical evaluation of this combination for its antitumor activity
Study NCT03414515 — intervention group
Intervention type: DEVICE
Intervention: Endovascular intervention
Description: Endovascular treatment with stent or balloon according to current practice
Study NCT05134142 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Undergo medical record review
Study NCT05134142 — intervention group
Intervention type: OTHER
Intervention: Physical Performance Testing
Description: Undergo physical performance testing
Study NCT05134142 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete assessments
Study NCT02439086 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET-CT Scan
Description: patients will have 2 PET CT scans: one before radiotherapy, and one 9 weeks after.
Study NCT05134142 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT04512352 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online curriculum
Description: The psychologist and our advisory team had successfully developed a total of 100 hours of parenting curriculum.~The adopted curriculum had focused on using play to facilitate parents in promoting their children's development in cognitive, motor, emotional and social aspects. Play-based activities are instrumental in improving children's development. Given that parents in poverty had difficulties spending time and money travelling back-and-forth to the training site and their homes, the research team decided to use e-learning as the medium of learning for our parenting programme. Web-based learning has the advantage of cutting time and travelling costs, which are luxuries to many parents in poverty.
Study NCT01592968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Assessment
Description: Ancillary studies
Study NCT01458171 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immune globulin subcutaneous (Human)
Description: IgPro20 is a 20% (weight per volume \[w/v\]) liquid formulation of human immunoglobulin for subcutaneous (SC) use. Subjects will receive weekly infusions of IgPro20 for a total of 24 weeks at a dose based on the subject's IgPro20 dose in the pivotal study ZLB06_002CR (NCT01199705).
Study NCT00022776 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical decompression
Description: Simple decompression not requiring fusion.
Study NCT00022776 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Physical therapy
Description: 2 physical therapy sessions per week for 6 weeks Followed by home program.
Study NCT04736784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food-based - beetroot juice
Description: Beetroot juice containing approximately 340 mg nitrate daily
Study NCT03457168 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Treatment of elevated asleep SBP mean
Description: To reduce asleep SBP mean determined by 48h ambulatory blood pressure monitoring up to the randomly assigned target by hypertension treatment intensification when required
Study NCT03809169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rapid on-site evaluation (ROSE)
Description: Pathologist on site for direct evaluation of specimen adequacy
Study NCT03809169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Slim bronchoscope without a guide sheath
Description: peripheral endobronchial ultrasound performed with a slim bronchoscope (3.0 mm outer diameter with a 1.7mm channel) combined with a radial ultrasound probe but without the use of a guide sheath.
Study NCT03809169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard pEBUS with guide sheath
Description: Using a flexible bronchoscope with minimal outer diameter of 4.2mm.
Study NCT04736784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food-based - leafy green vegetable juice
Description: Leafy green vegetable juice containing approximately 340 mg nitrate daily
Study NCT02466945 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: V063B-DP3003
Description: The medical device V063B-DP3003 has been developed to relieve and decrease dentinal hypersensitivity in patients by creating a film around the sensitive tooth in order to prevent pain. Application modalities: apply a pea size amount of product (around 0.5g) onto each of the sensitive teeth, 3 times a day, by gentle massage with clean finger after each brushing of teeth. Do not rinse
Study NCT02659059 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified Dose on Specified Days
Study NCT02659059 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Specified Dose on Specified Days
Study NCT02659059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum Doublet Chemotherapy
Study NCT03976102 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DRL_RI (Proposed rituximab biosimilar)
Description: Proposed rituximab biosimilar, 100mg and 500mg, concentrate for solution for infusion
Study NCT03976102 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MabThera®
Description: Reference product rituximab, 100mg and 500mg, concentrate for solution for infusion
Study NCT00761059 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucose 20%
Description: The oral application of 0,3 ml/kg Glucose 20% 3 minutes before nasopharyngeal suctioning
Study NCT00761059 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Aqua
Description: The oral application of 0,3 ml/kg Aqua 3 minutes before nasopharyngeal suctioning
Study NCT01739322 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Prick test Platanus acerifolia allergen extract
Description: This is an open, unblinded and non randomized biological as proposed by the Nordic Guidelines.~Four concentrations of Platanus acerifolia allergen extract, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. This test will be referred to as the Titrated Skin Prick test.
Study NCT02041455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin and Placebo
Study NCT02041455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amitriptyline and Placebo
Study NCT02041455 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin and Amitriptylin
Study NCT01541657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ankle Joint Mobilization
Description: The posterior ankle mobilization treatment is a manual therapy technique that consists of gently gliding your ankle in the backward direction through a pain free range of motion. This is a common therapy technique used by athletic trainers for the treatment of ankle sprains. The objective of this therapy technique is to glide the ankle into the area which restricts range of motion and gently stretch the restricted area. To begin this treatment, a certified athletic trainer with experience in applying this therapy technique will provide mild traction to the ankle joint to lightly distract the bones of the ankle joint. The athletic trainer will then apply two sets of joint mobilizations which will each last 2 minutes. Each repetition will consist of gently gliding the ankle joint in the backward direction until an area of restriction is reached. The athletic trainer will push into the restriction and then glide the ankle back to the starting position.
Study NCT01541657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Massage
Description: The foot massage treatment is a manual therapy technique that consists of gently rubbing the bottom of your feet with both hands like kneading dough. To begin the treatment, you will be asked to lie comfortably on a treatment table you're your feet hanging slightly off the edge. The athletic trainer with experience in applying this therapy will place his hands on the bottom of your foot and begin to massage your feet from your toes down to your heel. The athletic trainer will perform 2 sets of 2 minutes of massage with 1 minute rest in between sets.
Study NCT03662737 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Visuomotor adaptation task
Description: We will measure performance of the subjects of each group on the visuomotor adaptation task, especially in the rotation condition, in which a perturbation will be induced between the anticipated location of the hand and the provided visual feedback, and in the washout condition, in which the rotation will be removed. We expect that subjects with cannabis use disorder will not show the expected implicit motor adaptation to the perturbation and consequently no deterioration of performance on the task, due to cannabis-induced cerebellar damage. In other words, we want to show that this visuomotor task is a cheap and quick biomarker of cerebellar dysfunction in chronic cannabis users.
Study NCT01541657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calf Stretching
Description: The calf stretching treatment is a technique that is commonly used in sports and rehabilitation. You will be asked to place your foot on a slant board located next to a wall with your heel positioned below your toes on the slant board. You will be asked to lean towards the wall until you feel tension in your calf muscles that feels like a good stretch. You will perform 2 sets of 3 stretches that are held for 30 seconds each. Between each stretch, you will rest for 10 seconds. Between each set, you will rest for 1 minute.
Study NCT00755716 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (sugar pill)
Description: patients receive
Study NCT00755716 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topiramate
Description: 25 mg per day for one week, 50 mg per day for one week, 100 mg per day for one week, 200 mg per day for 5 weeks, then one week taper
Study NCT01224496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chinese herbal concoction twice a day for 6 months
Description: Definition of each TCM syndrome is based on TCM theory. Formulation composition is based on each defined TCM syndrome with addition or removal of herbs as indicated by the patient's manifestation
Study NCT03293342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: D CBT
Description: Intervention:~a 3-5 session treatment of dental fear.~* Psychoeducation about anxiety~* Exploration of the individual anxiety~* Exposure to the frightening stimuli (no hiding, but actively showing in detail all components of dental treatment, preferably utilizing a mirror while doing treatment).
Study NCT03293342 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Intervention:~Traditional treatment of dental fear common sense/ benzodiazepine